Tara H. Macrae
Montreal, QC H3T1J4, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications
CD33 epitope editing unlocks UM171-expanded cord blood grafts for AML immunotherapy.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: April 24, 2025
SF3B1 mutations provide genetic vulnerability to copper ionophores in human acute myeloid leukemia.
Journal: Science advances
Published: March 22, 2024
Vesicular trafficking is a key determinant of the statin response in acute myeloid leukemia.
Journal: Blood advances
Published: August 30, 2021
CDK7/12/13 inhibition targets an oscillating leukemia stem cell network and synergizes with venetoclax in acute myeloid leukemia.
Journal: EMBO molecular medicine
Published: August 14, 2021
HLF expression defines the human hematopoietic stem cell state.
Journal: Blood
Published: January 08, 2021
UM171 Preserves Epigenetic Marks that Are Reduced in Ex Vivo Culture of Human HSCs via Potentiation of the CLR3-KBTBD4 Complex.
Journal: Cell stem cell
Published: July 21, 2020
UM171 induces a homeostatic inflammatory-detoxification response supporting human HSC self-renewal.
Journal: PloS one
Published: July 10, 2019
Genetic characterization of ABT-199 sensitivity in human AML.
Journal: Leukemia
Published: March 06, 2019
Integrin-α3 Is a Functional Marker of Ex Vivo Expanded Human Long-Term Hematopoietic Stem Cells.
Journal: Cell reports
Published: October 12, 2018
Mubritinib Targets the Electron Transport Chain Complex I and Reveals the Landscape of OXPHOS Dependency in Acute Myeloid Leukemia.
Journal: Cancer cell
Published: June 30, 2018
Last Updated: 09/26/2026